Interim Budget 2019 Reaction - Pharmaceuticals - Mr. Gaurav Jain, Vice President - Corporate Ratings, ICRA

Impact - Marginally Positive

The Pharmaceutical sector will benefit from cascading effect of scale up in schemes such as Ayushman Bharat programme targeting health coverage for 50 crore citizens. The insurance scheme has benefitted 10 lakh people in last one year and the coverage/beneficiaries are expected to scale up going forward. This along with plans of universal healthcare coverage by 2030 augurs well for the Pharmaceutical sector in the longer run. Higher disposable income owing to tax rebates will allow higher spending on Pharmaceuticals in the near term.

Shares of ICRA LTD. was last trading in BSE at Rs.3019.95 as compared to the previous close of Rs. 3019. The total number of shares traded during the day was 511 in over 13 trades.

The stock hit an intraday high of Rs. 3019.95 and intraday low of 2997. The net turnover during the day was Rs. 1531732.

Source : Equity Bulls

Keywords